SMAD9 and pulmonary arterial hypertension: Additional risk factors impacting BMP/TGF-β signalling in PAH include SMAD8 (SMAD9) and caveolin-1 (CAV1), identified by candidate gene screening and whole-exome sequencing (WES), respectively.